{"prompt": "['LIST OF ABBREVIATIONS', 'ADT', 'androgen deprivation therapy', 'AE', 'adverse event', 'ALP', 'alkaline phosphatase', 'ALT', 'alanine aminotransferase', 'ANC', 'absolute neutrophil count', 'AR', 'androgen receptor', 'AST', 'aspartate aminotransferase', 'BICR', 'blinded independent central review', 'BMI', 'body mass index', 'BPI-SF', 'Brief-Pain Inventory Short Form', 'BUN', 'blood urea nitrogen', 'CFR', 'Code of Federal Regulations', 'CNS', 'central nervous system', 'CPET', 'cardiopulmonary exercise test', 'CR', 'complete response', 'CRF', 'case report form', 'CRP', 'c-reactive protein', 'CRPC', 'castration-resistant prostate cancer', 'CT', 'computed tomography', 'CTCAE', 'Common Terminology Criteria for Adverse Events', 'CVA', 'cerebrovascular accident', 'ECC', 'Exercise Coordinating Centre', 'ECG', 'electrocardiogram', 'ECOG', 'Eastern Cooperative Oncology Group', 'FACT-P', 'Functional Assessment of Cancer Therapy-Prostate', 'FACIT', 'Functional Assessment of Chronic Illness Therapy', 'FFPE', 'formalin-fixed paraffin-embedded', 'FFQ', 'food frequency questionnaire', 'GnRH', 'gonadotropin-releasing hormone', 'EQ-5D', 'EuroQOL five dimension questionnaire', 'GCP', 'good clinical practice', 'HDL', 'high density lipoprotein', 'HIIT', 'intensity interval training', 'HIPAA', 'Health Insurance Portability and Accountability Act', 'HPFS', 'Health Professionals Follow-up Study', 'HR', 'hazard ratio', 'HRmax', 'maximum heart rate', 'ICH', 'International Conference on Harmonisation', 'IDMC', 'Independent Data Monitoring Committee', 'IEC', 'Independent Ethics Committee', 'IGF-1', 'Insulin- like growth factor-1', 'LDL', 'low density lipoprotein', 'IL-1\u00df', 'Interleukin-1 beta', 'IL-2', 'Interleukin-2', 'IL-6', 'Interleukin- 6', 'INTERVAL Protocol Version 4.0, 19 April 2018', '6']['IV', 'intravenous', 'IRB', 'Institutional Review Board', 'LHRH', 'luteinizing hormone-releasing hormone', 'LPI', 'last patient in', 'M-CRPC', 'metastatic castration-resistant prostate cancer', 'MI', 'myocardial infarction', 'MRI', 'magnetic resonance imaging', 'NCI', 'National Cancer Institute', 'NFkb', 'nuclear factor kappa-light-chain-enhancer of activated B cells', 'Nrf-2', 'nuclear factor erythroid 2-related factor 2', 'os', 'overall survival', 'PCWG', 'Prostate Cancer Clinical Trials Working Group', 'PDWG', 'Protocol Development Working Group', 'PET', 'positron emission tomography', 'PFS', 'progression-free survival', 'PR', 'partial response', 'PSA', 'prostate-specific antigen', 'QALY', 'quality adjusted life years', 'QOL', 'quality of life', 'RCT', 'randomised controlled trial', 'RECIST', 'response evaluation criteria in solid tumours', 'RM', 'repetition maximum', 'RPE', 'rate of perceived exertion', 'SAE', 'serious adverse event', 'SCC', 'Site Coordinating Centre', 'SCT', 'social cognitive theory', 'SE', 'Supervised Exercise group (intervention group)', 'SDE', 'Self-directed Exercise group (control group)', 'SHBG', 'sex hormone binding globulin', 'SOC', 'standard of care', 'SOM', 'Study Operations Manual', 'SS', 'supplemental study', 'SSE', 'symptomatic skeletal related event', 'TBC', 'to be confirmed', 'TBD', 'to be determined', 'TIA', 'transient ischemic attack', 'TLS', 'total leisure score', 'TNM', 'tumour nodes metastasis', 'TPB', 'theory of planned behaviour', 'TTM', 'trans-theoretical model', 'ULN', 'upper limit of normal', 'VAS', 'visual analogue scale', 'VO2max', 'maximum oxygen uptake', 'WHO', 'World Health Organization', 'INTERVAL Protocol Version 4.0, 19 April 2018', '7']\n\n###\n\n", "completion": "END"}